ℹ️
🇬🇧
Search
Search for publications relevant for "CYP1A1-Ren-2"
CYP1A1-Ren-2
Publication
Class
Person
Publication
Programmes
publication
Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension
2009 |
First Faculty of Medicine
publication
Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension
2009 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
publication
Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats
2009 |
Second Faculty of Medicine
publication
Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats
2016 |
Second Faculty of Medicine, Central Library of Charles University
publication
20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats
2018 |
First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
publication
Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats
2010 |
Second Faculty of Medicine
publication
Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: Studies in Cyp1a1-Ren-2 transgenic rats
2014 |
Second Faculty of Medicine
publication
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats
2016 |
Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
publication
Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats
2016 |
Second Faculty of Medicine, Central Library of Charles University, Faculty of Science
publication
Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats
2011 |
First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
publication
Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats
2011 |
Second Faculty of Medicine
publication
AT(1) receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1 Ren-2 transgenic rats with inducible hypertension
2006 |
Second Faculty of Medicine
publication
Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME
2013 |
Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
publication
Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension
2011 |
Second Faculty of Medicine, Central Library of Charles University
publication
Inappropriate activation of the renin-angiotensin system improves cardiac tolerance to ischemia/reperfusion injury in rats with late angiotensin II-dependent hypertension
2023 |
Second Faculty of Medicine